Products

SEP EFA contains a high concentration of eicosapentenoic acid (EPA) and docosahexenoic acid (DHA) from salmon oil for maximum support and maintenance of cardiovascular and neurological health. Studies show that EPA is needed by the body for the production of PG3 prostaglandins, which possess potent anti-clotting and aggregating properties. Deficiency in essential fatty acids may cause hardening of the arteries and heart, leading to cardiovascular disease. SEP EFA is indicated for conditions associated with cardiovascular disorders, including hypertension, angina, high blood pressure, arteriosclerosis, strokes, arrhythmias, arterial plaque buildup, high cholesterol and blood clotting; and for diabetic complications such as retinal damage, gangrene and kidney disorders.

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.